ReadingThe treatment of chronic renal failure presents unique problems in nutrition and the patients, maintained on closely restricted diets, are eminently suitable for nutritional studies. Conventional treatment involves the use of high-calorie diets providing 18-20 g proteinjday (Giovannetti & Maggiore, 1964) which, although maintaining a precarious nitrogen balance, are deficient in vitamins and iron. With the advent of regular dialysis treatment (RDT) it became possible to allow a more generous protein intake (50-70 g) but the prolonged cooking times and the leaching effect of large volumes of water necessary to rid the diet of excess sodium and potassium reduced the content of most vitamins to well below the accepted daily requirements. I n addition, there was a significant dialysis loss of vitamins during treatment. I n six patients established on RDT, thiamine, nicotinic acid, pantothenic acid, biotin and vitamin R, were all lost during dialysis, in amounts approximately equal to the 24 h urine loss in healthy adults. Folic acid and riboflavine were lost in considerably greater amounts, but there was no detectable loss of vitamin BIZ. All the patients had low plasma folate, averaging 3-9 ng/ml as compared with the normal range of 6-18 ng/ml, and indeed megaloblastic marrow changes, attributed to folate deficiency, have been reported in chronic renal failure. T h e R D T diet supplied daily only 74 pg free folate, compared with about ZOO pg in normal diets. Loss of folate during 14 h dialysis averaged 80 pg, calculated from the drop in plasma folate across the dialyser, or 30 pg from direct assay of folate in the dialysing fluid.Studies with tritiated folk acid showed normal absorption from the gut, and so the low plasma folate presumably reflects an adverse equilibrium between dietary intake of the vitamin, the losses during dialysis and the requirements for metabolism. Nevertheless there was no progressive depletion of tissue stores as indicated by the red cell folate, which remained within the normal range during the period of this study. Furthermore, early megaloblastic marrow changes observed in the patients did not respond to saturation doses of folic acid.